Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
Cash from Operating Activities
Intersect Ent Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
Cash from Operating Activities
-$69.4m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Intersect Ent Inc's Cash from Operating Activities?
Cash from Operating Activities
-69.4m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Cash from Operating Activities amounts to -69.4m USD.
What is Intersect Ent Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-30%
Over the last year, the Cash from Operating Activities growth was -49%. The average annual Cash from Operating Activities growth rates for Intersect Ent Inc have been -60% over the past three years , -30% over the past five years .